The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

National Taiwan University

Status: Completed

Conditions: With APACH II Score >25); With ECMO or IABP Support,; Cardiogenic Shock,

Study type: Observational

Funder types: Other

Identifiers

NCT01993745

200804046R

Details and patient eligibility

About

The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients

Full description

The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score >25)

Enrollment: 106 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score >25)

Exclusion criteria

• pacemaker rhythm, not sign the permit

Trial design

106 participants in 2 patient groups

Study group

Description:

ECMO Patients survived

Control

Description:

ECMO Patient died